Navigation Links
Neuralstem, Inc. to Present At World Stem Cells and Regenerative Medicine Congress
Date:5/10/2010

ROCKVILLE, Md., May 10 /PRNewswire-FirstCall/ -- Neuralstem, Inc. (NYSE Amex: CUR) CEO and President, Richard Garr, has been invited  to present at the Fifth Annual World Stem Cells and Regenerative Medicine Congress, held May 11-13, in London, UK http://www.terrapinn.com/2010/stemcells/index.stm. Neuralstem is currently in a Phase I clinical trial to treat ALS (Amyotrophic Lateral Sclerosis, or Lou Gehrig's disease) with its spinal cord stem cells.

(Logo: http://www.newscom.com/cgi-bin/prnh/20061221/DCTH007LOGO )

Mr. Garr's talk, at 2:30 on Wednesday, May 12, is entitled  "Goals, Challenges and Solutions for Bringing Cell-Based ALS Therapy to the Clinic."  It will address the goals and scientific potential of applying cell therapy to ALS, as well as the challenges and solutions in bringing this treatment to patients.

About Neuralstem, Inc.

Neuralstem's patented technology enables, for the first time, the ability to produce neural stem cells of the human brain and spinal cord in commercial
'/>"/>

SOURCE Neuralstem, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. American Stock Exchange Lists The Common Stock Of Neuralstem, Inc.
2. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Neuralstem, Inc.
3. Neuralstem, Inc. Reports Third Quarter Financial Results and Provides Business Update
4. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
5. Avicena Group to Present at Noble Financial Conference
6. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
7. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
8. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
9. CEL-SCI to Present at the Noble Financial Conference
10. Lexicon Presents Class of Compounds Modulating TPH1, the Target for its LX1031 Investigational Drug for Irritable Bowel Syndrome
11. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... The Pittcon Organizing Committee is pleased to announce that ... an e-Journal and producer of Food Labs Conference ... for the co-location of Food Labs Conference to be held ... registration fee to attend the two-day Food Lab Conference, March ...
(Date:1/15/2014)... England and SAN JOSE, California ... international biotechnology company developing antibody-drug conjugates for cancer, today announced ... Board of Directors. Dr Reynolds has over 20 years, development ... Medical Officer at Seattle Genetics. "I am delighted ...
(Date:1/15/2014)... Houston, TX (PRWEB) January 15, 2014 ... Alzheimer’s disease, and about 1 in 3 seniors will ... ( source ). These jaw-dropping figures have shocked many ... function and, hopefully, help prevent these tragic age-related cognitive ...
(Date:1/15/2014)... January 15, 2014 2013 was a ... Brain State Technologies®. They saw continued independent research led ... who were awarded a $1 million grant from the ... “Brain and Behavior” a peer reviewed journal, Amy Grant ...
Breaking Biology Technology:Pittcon Announces Second Year Partnership With Food Safety Tech 2Pittcon Announces Second Year Partnership With Food Safety Tech 3Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3Biohack Pure Offers 5 Tips for Increasing Memory in 2014 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3
... Innovations, Inc. (NYSE: IMA ), a global leader in ... through the merger of rapid diagnostics and health management, today ... on Tuesday, October 27, 2009. The Company will also host ... that date to discuss these results and other corporate matters. ...
... Senomyx, Inc. (Nasdaq: SNMX ), a leading company ... and develop novel flavor ingredients for the food, beverage, ... the Company,s President and Chief Operating Officer, will present ... p.m. Pacific Time (4:30 p.m. Eastern Time) during the ...
... announced a collaboration with Photron USA Inc., a ... software, to develop specialized instrumentation for the CNSI,s ... an international photo-instrumentation company that provides photo-optics and ... to furthering scientific research and development through the ...
Cached Biology Technology:Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET October 27, 2009 to Discuss Third Quarter 2009 Results 2SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE 2009 BIOCOM INVESTOR CONFERENCE 2
(Date:4/17/2014)... recent Yokahama IPCC meeting painted a stark warning on ... which has a greenhouse effect 32 times that of ... shown that humic substances act as fully regenerable electron ... are held in wetlands instead of being released to ... system is disrupted it may enter into a vicious ...
(Date:4/17/2014)... the genetic information of DNA is used to ... numerous different functions in living organisms. Messenger RNA ... expression, by relating the genetic information of DNA ... , By examining the different types and ... at a given time, researchers can determine which ...
(Date:4/17/2014)... way the immune system may fight cancers and viral ... cells to treat illness. , The research, in mice, ... "neighborhood police" specialized squads of defenders that patrol ... entire city, the body. , Scientists at Washington University ... the liver, skin and uterus each has dedicated immune ...
Breaking Biology News(10 mins):Methane climate change risk suggested by proof of redox cycling of humic substances 2Rapid and accurate mRNA detection in plant tissues 2Some immune cells defend only 1 organ 2
... Warming in the North Atlantic over the last 32 years ... breeding grounds, resulting in sharply higher death rates among seal ... study. "The kind of mortality we,re seeing in ... from the population in low ice years essentially all ...
... January article highlights:, Seriously, we,re poisonous: Coloration is an ... butterflies recognize their compatriots in a world of mimics, Researchers ... for an ant colony, A rough start for a hatchling ... complete list of articles in the January issue, go to ...
... 2012 Basmajian Award will be presented on April 24 ... cell biology, neurobiology and anatomy at the Medical College ... the AAA Annual Meeting at EB 2012 (Tuesday, April ... CA)., This award recognizes health science faculty who are ...
Cached Biology News:Harp seals on thin ice after 32 years of warming 2Seriously, we're poisonous: Coloration is an honest signal of toxicity in poison frogs 2Seriously, we're poisonous: Coloration is an honest signal of toxicity in poison frogs 3Seriously, we're poisonous: Coloration is an honest signal of toxicity in poison frogs 4Todd Hoagland honored by Anatomy Society for excellence in teaching, research & scholarship 2
...
Quinolinate phosphoribosyltransferase...
This antibody is specific for human J-chain as defined by ELISA assay using purified human immunoglobulin fragments as solid phase target antigen....
Tissue-Stat ( Tissue Adherent for Mounting Formalin-Fixed and Frozen Tissue Sections.)...
Biology Products: